Tyra Biosciences
TYRA
TYRA
117 hedge funds and large institutions have $500M invested in Tyra Biosciences in 2025 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 113 → 117 (+4)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
26% less capital invested
Capital invested by funds: $676M → $500M (-$176M)
Holders
117
Holding in Top 10
4
Calls
$233K
Puts
$50K
Top Buyers
| 1 | +$17.6M | |
| 2 | +$17.4M | |
| 3 | +$9.25M | |
| 4 |
CC
Commodore Capital
New York
|
+$8.84M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$8.45M |
Top Sellers
| 1 | -$28.2M | |
| 2 | -$13M | |
| 3 | -$2.78M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$1.39M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$631K |
